By: Davidta Brown, Staff Editor – For the estimated 7.5 million individuals in the United States living with iron deficiency anemia (IDA), there is now a new alternative to iron supplements or time-consuming, repetitive infusions. On July 25, 2013, the FDA approved ferric carboxymaltose injection (Injectafer®) for the treatment of IDA, especially in patients who…

By: Ada Seldin, Staff Editor – On August 12,2013, a new weapon against HIV-1 infection was added to the existing armada. Dolutegravir, the third integrase strand transfer inhibitor to attain FDA approval, targets a protein essential to HIV replication. HIV-1 is the predominant type of HIV virus, the other being HIV-2, which is endogenous to…

By: Lauren Kaveski, Pharm.D. Candidate c/o 2013 – We see proton pump inhibitors (PPIs) used in many medication regimens, but it is unknown whether the majority of patients receive these medications for appropriate durations or indications.  For all labeled indications, other than Zollinger-Ellison Syndrome (a rare condition characterized by damaging gastrin hypersecretion and subsequent hydrochloric…

By: Simardeep Singh, Pharm.D. Candidate c/o 2013 – In February I  had the opportunity of doing an Advanced Pharmacy Practice Experience (APPE) rotation at an industry site that did not involve me commuting to New Jersey. American Regent Inc. is a subsidiary of Luitpold Pharmaceuticals and operates out of Shirley, Long Island located conveniently off…

By: Marie Huang – As the studio lights dimmed and the dynamic music played in the background, many students gathered in St. Albert Hall B75 in anticipation of who will be crowned the game’s next “PharmD.” A competitive air dangled, but the crowd chattered excitedly as a generous lunch was provided. Four seats lined the…